A plasmid, Rms425, mediating resistance to streptomycin(Sm) and mercury(Hg) was isolated from Pseudomonas cepacia GN11131 of clinical origin. Rms425 was transferred to Pseudomonas cepacia, Pseudomonas aeruginosa and Escherichia coli strains by transformation with purified DNA and by conjugation between isogenic strains of P. aeruginosa or of E. coil by mixing on membrane filters. The molecular weight of Rms425 was estimated to be about 32 megadaltons by electron microscopy and it was classified as incompatibility group P.
Pseudomonas cepacia strains have recently been isolated with increasing frequency from clinical specimens, and most of them are found to be resistant to antimicrobial agents, especially to aminoglycoside antibiotics.
We wished to know whether the resistance to aminoglycosides was mediated by plasmids, and found that among five representative strains of clinical origin resistant to Sm, Km(kanamycin) or Gin (gentamicin) one strain carried a plasmid mediating Sm(streptomycin) resistance. GONZALEZ et al.1) isolated plasmids from several strains of P. cepacia, but no phenotypic function was assigned to any of these plasmids. The first isolation of drug-resistant plasmids from tetracycline or ampicillin resistant P. cepacia strains was reported by WILLIAMS et al.2) . This paper describes the properties of the plasmid mediating Sm resistance in P. cepacia GN11131 and the biochemical mechanism of the Sm resistance mediated by this plasmid.
Materials and Methods

Bacterial Strains
Pseudomonas cepacia strains were isolated from clinical specimens and stocked in this laboratory. Pseudomonas aeruginosa PAO2142 (met, ilt, lys) strains resistant to rifampicin (Rpr) or to nalidixic acid (Nar), E. coli K-12 strains X1037 (gal, hsd, lac, met, rel, sup) and ML1410 (Nar, met), and P. cepacia ML 5062 Rpr were used for transformation and mating experiments. ML5062 is a mutant of GN11131 which spontaneously lost resistance to both Sm and Hg. R Factors belonging to different incompatibility groups were used to determine the incompatibility type of the R plasmids. These were kindly supplied by N. DATTA (Royal Postgraduate Medical School, London). Incompatibility tests were carried out by the method of DATTA and HEDGES3,4). Chemicals Streptomycin (Sm), spectinomycin (Sp), kanamycin (Km), tetracycline (Tc), chloramphenicol (Cm), sulfonamide (Su), gentamicin (Gm), carbenicillin (Cb), ampicillin (Ap), nalidixic acid (Na), and rifampicin (Rp) were used. Mercuric chloride (Hg) was obtained commercially. The isotope-labelled preparations of ATP, i.e., [--32P] ATP (926 pCi/ml) and [8-14C] ATP (50 1tCi/ml), were purchased from the Radiochemical Centre, Amersham, England. Media Antibiotic medium 3 (Difco) and L-broth were used for liquid cultures of bacterial strains. For the determination of drug resistance, heart infusion agar (Eiken Chemical Co., Tokyo) and peptone water were used. The peptone water consisted of 1,000 ml of distilled water, 5 g NaCI, and 10 g peptone. Bromothymol blue (BTB)-lactose agar containing selective drugs was used as the selective medium for the transformants or transconjugants.
BTB agar consisted of nutrient broth (10 g beef extract, 10 g peptone and 3 g NaCI in 1,000 ml distilled water) supplemented with 80 mg BTB and 15 g agar.
Determination of Drug Resistance Drug resistance was determined by the agar dilution method, and the level of resistance was expressed as the minimum inhibitory concentration (MIC) of a drug. An overnight culture in peptone water was diluted 10,000-fold with BSG, which consisted of 1,000 ml of distilled water, 8.5 g NaCl, 0.3 g KH2PO4i 0.6 g Na2HPO4, and 0.1 g gelatin. One loopful (5 al) of the diluted culture was spotted on a series of agar plates containing serial two-fold dilutions of a drug. After 18 hours of incubation at 37°C, the bacterial growth was scored. Isolation of Plasmid DNA Plasmid DNA was isolated from P. cepacia GN11131 and P. aeruginosa PA02142 carrying the R plasmid. Cells were lysed with a Triton X-100, and after sedimenting the bulk of chromosomal DNA, plasmid DNA was separated and purified by density gradient centrifugation in cesium chloride in the presence of ethidium bromide, as described by KUPERSZTOCH et al.5) .
Transformation Transformation of (Sm•Hg) resistance in P. cepacia or P. aeruginosa with plasmid DNA was followed the method described by SANG and KAGEYAMA6), and that of E. coli K-12 X 1037 was followed the method described by COHEN et al.7). BTB lactose agar supplemented with Rp (100 trg/ml) and either Sm (25 ttg/ml) or Hg (12.5 ,ug/ml) was used for the selective plates.
Transfer of Drug Resistance
The transfer in liquid medium was carried out by mixing one part of the donor culture and nine parts of the recipient culture in the stationary phase of growth, followed by 2 hours incubation at 30°C or 37°C. Transfer on the membrane-filter was performed as follows. Five-milliliter portions of the 1: 9 mixtures of donor and recipient cultures in the stationary phase were filtered through Millipore filters (Millipore Corp., pore size: 0.45 ttm). The membranes which retained bacterial cells were incubated at 30°C or 37°C for 2 hours on the surface of BTB-lactose agar plates. Appropriate dilutions of the suspension were plated on BTB-lactose agar containing drugs. Concentration of drugs (µg/ml) for the selection of transconjugants were Na (100 ,ug/ml), Sm (12.5 pg/ml), and Hg (12.5 p.-/ml) for E. coli ML1410 (Nar), and Sm (12.5 pg/ml), Hg (12.5 jig/ml), and Na (400 ftg/ml) for P. aeruginosa PA02142 Nar.
Electron Microscopy Contour lengths were measured by enlarging the photographs of circular DNA Molecules. The double-stranded replicative form of a phage fd DNA8) was used as standard for the length measurement of the molecules.
Preparation of the S-30 Fraction and Inactivation Reaction of Sm The S-30 fractions, the supernatant of 30,000xg centrifugation, from P. cepacia, P. aeruginosa, and E. coli strains were prepared by the procedure described previously9,10). The reaction mixture consisted of 0.2 ml of 0.5 M tris-HCl buffer (pH 8.0), 0.05 ml of 20 mm ATP, 0.05 ml of 0.02 M magnesium acetate, 0.05 ml of 0.5 mm Sm, and 0.15 ml of the S-30 fraction. After incubation at 37°C for 5 hours, the reaction was stopped by heating in boiling water for 1 minute. Residual antibiotic activity in the reaction mixture was determined by bioassay using Bacillus subtilis ATCC6633.
Radio-isotope Assay for ATP Incorporation into Sm
The incorporation of [14C]ATP or [p-32P] ATP into Sm by Sm-inactivating enzyme was carried out by the procedure described previously11). The reaction mixture consisted of 30 lcl of the S-30 fraction (10 mg of protein/ml), 10 pl of 0.02 M magnesium acetate, 10 Id of 0.5 mm Sm, 40 pl of 0.5 M trisHCl buffer (pH 8.0), and 1 µl of [r 32P] ATP or 10 ,u.1 of [14C] ATP. The reaction was carried out at 37°C for 1 hour. The reaction mixture was pipetted onto a disk of phosphocellulose paper (Whatman P-81), washed with distilled water, and dried. Radioactivity was counted in a toluene-based scintillator with a liquid scintillation counter (Packard Instrument).
Results
Inactivation of Sm by P. cepacia Strains We selected five P. cepacia strains from our stock cultures (80 strains) with reference to patterns of resistance to aminoglycoside antibiotics such as Sm, Km, and Gm ( Each of the bands was collected, examined under electron microscopy, and used for transformation. We found the circular DNA as an OC form in the upper band, and only sheared fragments were detected in the lower band.
Using the 20 pl of upper-band DNA, (Sm • Hg) resistance could be transferred to P. aeruginosa PA02142 Rpr and P. cepacia ML5062 Rpr by transformation (Table 2, Exp. 1). CCC plasmid DNA could be detected in cesium chloride density gradients of the DNA form PAO2142 Rpr transformants.
This plasmid was called Rms425. The plasmid DNAs from PA02142 Rpr (Sm • Hg)r were used for further transformation of the recipient strains of P. cepacia, P. aeruginosa, and E. coli (Table 2 , Exp. 2). The number of transformants of P. cepacia ML5062, P. aeruginosa PA02142 Rpr, and E. coil X1037 Rpr were 10, 220, and 50 colonies per recipient culture (107 cells), respectively. All were resistant to both Sm and Hg, even when selected with either drug, indicating that the genes governing resistance to Sm and Hg were located on plasmid Rms425. The transformants were sensitive to all of the other antibiotics tested, i.e., Gm, Km, Sp, Su, Tc, Cb, and Ap. All transformants of P. cepacia, P. aeruginosa, and E. coil inactivated Sm.
Genetic Properties of Rms425
The transferability of (Sm.Hg) resistance in P. cepacia GN11131 and in the transformants of P.
aeruginosa PA02142 Rpr and E. coil X1037 Rpr was examined using P. cepacia ML 5062 Rpr, p. aeruginosa PA02142 Nar, and E. coil ML 1410 as recipient strains by mixing in liquid medium or on membrane filters. The results obtained by mixing on membrane filters are shown in Table 3 . No transfer from P. cepacia GN11131 to various recipients was detected. However, P. aeruginosa PA02142 Rpr
Rms425+ could transfer its resistance to P. aeruginosa PA02142 Nar at a low frequency. Similarly, E. coli X1037 Rpr Rms425+ could transfer the plasmid to E. coil ML1410 Nar. But Rms425 was nontransmissible between P. aeruginosa and E. coli strains. When mixed in liquid medium, no transfer was detectable in all combinations of donors and recipients when selected by either Sm or Hg. Incompatibility testing of Rms425 was performed using indicator R plasmids belonging to different incompatibility groups. Each of these R plasmids was conjugally transferred to E. coil X1037 Rpr or E. coil X1037 Rpr Rms425+.
Only the transfer frequency of RN (group P) was reduced (approximately 1,000-fold by the presence of Rms425 in the recipients, and (Sm-Hg) resistance conferred by Rms425 was Table 3 . Transfer of (Sm • Hg) resistance by mixing on membrane filters. Transfer frequency was expressed as the ratio of the number of transconjugants to that of donor cells.
eliminated from the transconjugants by the incoming RP4. On the contrary, the transfer frequencies of R40a (group C), N-3 (group N), S-a (group W), R391 (group J), or R1 (group FII) were not reduced by Rms425, and each of these plasmids coexisted with Rms425 in the recipients. We therefore conclude that Rms425 belonged to the incompatibility group P.
The molecular nature of Rms425 was examined by electron microscopy and its open circular form is shown in Fig. 1 We investigated the biochemical mechanisms of Sm resistance by incubation with cell-free extracts from P. aeruginosa PA02142 Rms425+ and E. coli X1037 Rms425+.
The results indicated that Rms425 encoded an enzyme that inactivated Sill by phosphorylation (Table 4) . Plasmids have been reported in P. cepacia1); however, the isolation of drug-resistance plasmids from P. cepacia strains has only been described by WILLIAMS et al.12). The plasmids , pJW2 and pJW3, mediated, respectively, resistance to tetracycline and ampicillin.
We have isolated a resistance plasmid Rms425 which mediated (Sm • Hg) resistance from a clinical isolate of P. cepacia GNI1131. The plasmid DNA was clearly detected in P. aeruginosa strains after transformation with GN11131 DNA. Difficulties in the isolation of the plasmid DNA as a ccc form from P. cepacia strains might be due to nuclease activity of P. cepacia as described by WILLIAMS et al.12) . The molecular weight of Rms425 isolated from P. aeruginosa PA02142 transformants was 32.4 Mdal; larger than pJW2 and pJW3, which were presumed to be nonconjugative because of their smaller sizes , i.e., 2.9 Mdal and 5.4 Mdal, respectively.
Plasmid Rms425 belongs to incompatibility group P, and was classified in the P-1 group in P . aeruginosa. As reported by DATTA et al.13,14> the R plasmids of incompatibility group P could be transferred to P. aeruginosa as well as E. coli. Rms425 might be slightly defective in transferability, because it was only transmissible between isogenic strains, i.e., between P. aeruginosa or between E. coli at an extremely low frequency by filter mating, but not between heterogenic species or by mixing in broth. Furthermore, Rms425 was not transmissible from P. cepacia GN11131 to any of the organisms tested, including an isogenic strain ML5062 Rpr. On the other hand, Rms425 was able to replicate and express (Sm.Hg) resistance in P. cepacia, P. aeruginosa, and E. coli and the transformants carrying Rms425 stably maintained their (Sm . Hg) resistance in the new hosts.
Enzymatic inactivation of aminoglycoside antibiotics is considered to be one of the main mechanisms of resistance in Gram-negative and Gram-positive pathogens isolated from clinical specimens . However, we could not detect any enzymes inactivating Sm, Km or Gm in resistant P. cepacia strains with the exception of GN11131. SM-inactivating enzymes in Sm-resistant strains of E. coli15), P. aeruginosa16,17)P. lachrymans18) , and Staphylococcus aureus11) , have two mechanisms, either pho-OF ANTIBIOTICS 
